Y. Barra
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism 6
-
- Drug Transport and Resistance Mechanisms 5
- Polyomavirus and related diseases 3
-
- NF-κB Signaling Pathways 3
-
- Bacteriophages and microbial interactions 3
-
- Glycosylation and Glycoproteins Research 2
- Epigenetics and DNA Methylation 2
- RNA Interference and Gene Delivery 2
- Co-authors
- Eric SéréeM. PlacidiPatrick MaurelBruno LacarelleXiaojing ZhouGregory D. JayRaphaël RahmaniJ E Coligan
- Cited by
- PharmacologyOncologyCancer Research
- Journals
- Biochemical and Biophysical Research Communications (7 papers)JNCI Journal of the National Cancer Institute (2 papers)Molecular Pharmacology (2 papers)
- Partner nations
- FranceMoroccoMontenegro
In The Last Decade
Y. Barra
28 papers receiving 630 citations
Peers
Comparison fields: 5 of 92
- Pharmacology 189
- Oncology 219
- Cancer Research 88
- Pediatrics, Perinatology and Child Health 89
- Health, Toxicology and Mutagenesis 60
Countries citing papers authored by Y. Barra
This map shows the geographic impact of Y. Barra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. Barra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. Barra more than expected).
Fields of papers citing papers by Y. Barra
This network shows the impact of papers produced by Y. Barra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. Barra. The network helps show where Y. Barra may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Y. Barra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 25 | |
| 2 | 2003 | 3 | |
| 3 | 2001 | 1 | |
| 4 | 2001 | 49 | |
| 5 | 2000 | 20 | |
| 6 | 1999 | 25 | |
| 7 | 1998 | 46 | |
| 8 | Effect of new thioacridine derivatives on P-gp function and on mdr1 gene expression. | 1998 | 18 |
| 9 | 1997 | 13 | |
| 10 | 1996 | 38 | |
| 11 | 1996 | 1 | |
| 12 | 1995 | 1 | |
| 13 | 1994 | 12 | |
| 14 | 1994 | 45 | |
| 15 | 1993 | 45 | |
| 16 | [Expression of oncogenes C-myc, C-raf and N-ras in advanced cancers of the upper respiratory and digestive tracts. Correlation with tumor clinical response to chemotherapy]. | 1993 | 1 |
| 17 | Involvement of human liver cytochrome P450 3A in vinblastine metabolism: drug interactions. | 1993 | 124 |
| 18 | 1984 | 61 | |
| 19 | 1975 | 2 | |
| 20 | 1973 | 4 |
About Y. Barra
Y. Barra is a scholar working on Pharmacology, Oncology, Cancer Research, Molecular Biology and Pharmaceutical Science, having authored 28 papers that have together received 652 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (6 papers), Drug Transport and Resistance Mechanisms (5 papers), Bacteriophages and microbial interactions (3 papers), Polyomavirus and related diseases (3 papers), NF-κB Signaling Pathways (3 papers), Glycosylation and Glycoproteins Research (2 papers), Epigenetics and DNA Methylation (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Pharmacology (189 citations), Oncology (219 citations), Cancer Research (88 citations), Pediatrics, Perinatology and Child Health (89 citations) and Health, Toxicology and Mutagenesis (60 citations). Y. Barra has collaborated with scholars based in France, Morocco and Montenegro. Frequent co-authors include Eric Sérée, M. Placidi, Patrick Maurel, Bruno Lacarelle, Xiaojing Zhou, Gregory D. Jay, Raphaël Rahmani, J E Coligan, W L Maloy and Serge Champion. Their work appears in journals such as Biochemical and Biophysical Research Communications, JNCI Journal of the National Cancer Institute, Molecular Pharmacology, Proceedings of the National Academy of Sciences and Biopharmaceutics & Drug Disposition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.